BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3887901)

  • 1. Defining the physiologic and pathophysiologic roles of renin: the role of specific inhibitors.
    Haber E
    Am J Kidney Dis; 1985 Apr; 5(4):A14-22. PubMed ID: 3887901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Will renin inhibitors influence decision-making in antihypertensive therapy?
    Haber E
    J Hypertens Suppl; 1985 Nov; 3(2):S71-80. PubMed ID: 3003303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The first Sir George Pickering memorial lecture. Which inhibitors will give us true insight into what renin really does?
    Haber E
    J Hypertens; 1984 Jun; 2(3):223-30. PubMed ID: 6099385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is renin a factor in the etiology of essential hypertension?
    Haber E; Zusman R; Burton J; Dzau VJ; Barger AC
    Hypertension; 1983; 5(6 Pt 3):V8-15. PubMed ID: 6418650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide inhibitors of renin in cardiovascular studies.
    Haber E
    Fed Proc; 1983 Dec; 42(15):3155-61. PubMed ID: 6196232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of renin: present and future.
    Haber E
    Clin Exp Hypertens A; 1983; 5(7-8):1193-205. PubMed ID: 6357563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.
    Sawyer TK; Pals DT; Mao B; Staples DJ; de Vaux AE; Maggiora LL; Affholter JA; Kati W; Duchamp D; Hester JB
    J Med Chem; 1988 Jan; 31(1):18-30. PubMed ID: 3275777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The His-Pro-Phe motif of angiotensinogen is a crucial determinant of the substrate specificity of renin.
    Nakagawa T; Akaki J; Satou R; Takaya M; Iwata H; Katsurada A; Nishiuchi K; Ohmura Y; Suzuki F; Nakamura Y
    Biol Chem; 2007 Feb; 388(2):237-46. PubMed ID: 17261087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the specificity of human renin. Studies with peptide inhibitors.
    Poulsen K; Haber E; Burton J
    Biochim Biophys Acta; 1976 Dec; 452(2):533-7. PubMed ID: 1009126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Renin inhibition by peptides and pseudo-peptides].
    Corvol P
    Nephrologie; 1989; 10(2):65-71. PubMed ID: 2677816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific inhibition of renin by an angiotensinogen analog: studies in sodium depletion and renin-dependent hypertension.
    Burton J; Cody RJ; Herd JA; Haber E
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5476-9. PubMed ID: 6159648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of renin and their utility in physiologic studies.
    Haber E; Burton J
    Fed Proc; 1979 Dec; 38(13):2768-73. PubMed ID: 510563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological interferences with the renin-angiotensin system.
    Ganten D; Unger T; Lang RE
    Arzneimittelforschung; 1984; 34(10B):1391-8. PubMed ID: 6097263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analogue inhibitors containing a novel analogue of statine.
    Boger J; Payne LS; Perlow DS; Lohr NS; Poe M; Blaine EH; Ulm EH; Schorn TW; LaMont BI; Lin TY
    J Med Chem; 1985 Dec; 28(12):1779-90. PubMed ID: 3906131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic factors involved in renovascular hypertension. State of the art.
    Bumpus FM; Khosla MC
    Mayo Clin Proc; 1977 Jul; 52(7):417-23. PubMed ID: 327161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pepstatin analogues as novel renin inhibitors.
    Guégan R; Diaz J; Cazaubon C; Beaumont M; Carlet C; Clément J; Demarne H; Mellet M; Richaud JP; Segondy D
    J Med Chem; 1986 Jul; 29(7):1152-9. PubMed ID: 3543358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent in vivo inhibitors of rat renin: analogues of human and rat angiotensinogen sequences containing different classes of pseudodipeptides at the scissile site.
    Sueiras-Diaz J; Jones DM; Szelke M; Leckie BJ; Beattie SR; Beattie C; Morton JJ
    J Pept Res; 1997 Oct; 50(4):239-47. PubMed ID: 9352462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. George C. Griffith lecture. The role of renin in normal and pathological cardiovascular homeostasis.
    Haber E
    Circulation; 1976 Dec; 54(6):849-61. PubMed ID: 791534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why renin inhibitors?
    Haber E
    J Hypertens Suppl; 1989 Apr; 7(2):S81-6. PubMed ID: 2666619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning, characterization and site-directed mutagenesis of canine renin.
    Bukhtiyarov Y; Zecher M; Panemangalore R; Wu Z; Bruno JG; Yuan J; Xu Z; Dillard LW; McGeehan GM; Harrison RK; Scott BB
    J Biochem; 2007 Dec; 142(6):671-80. PubMed ID: 17942478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.